IMMUNOLOGICAL EVALUATION OF MALIGNANT DISEASE - DIAGNOSIS, PROGNOSIS, AND MANAGEMENT

被引：12

作者：

HERSH, EM ^{[1
]}

MAVLIGIT, GM ^{[1
]}

GUTTERMAN, JU ^{[1
]}

机构：

[1] UNIV TEXAS, MD ANDERSON HOSP & TUMOR INST, CTR SYST CANC, DEPT DEV THERAPEUTICS, HOUSTON, TX 77025 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1976年 / 236卷 / 15期

关键词：

D O I：

10.1001/jama.236.15.1739

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1739 / 1742

页数：4

共 52 条

[1] AISENBERG AC, 1966, CANCER-AM CANCER SOC, V19, P385, DOI 10.1002/1097-0142(196603)19:3<385::AID-CNCR2820190312>3.0.CO
[2] 2-S
[3] INCREASED TUMOUR INDUCTION BY ADENOVIRUS TYPE 12 IN THYMECTOMIZED MICE AND MICE TREATED WITH ANTI-LYMPHOCYTE SERUM
ALLISON, AC
BERMAN, LD
LEVEY, RH
[J]. NATURE, 1967, 215 (5097) : 185 - &
[4] BLOCK JB, 1969, J NATL CANCER I, V42, P973
[5] BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1
[6] CATALONA WJ, 1973, CANCER, V31, P65, DOI 10.1002/1097-0142(197301)31:1<65::AID-CNCR2820310109>3.0.CO
[7] 2-Y
[8] CHASE MW, 1966, CANCER RES, V26, P1097
[9] CHEEMA AR, 1971, CANCER, V28, P851, DOI 10.1002/1097-0142(1971)28:4<851::AID-CNCR2820280408>3.0.CO
[10] 2-E